摘要
因阿尔茨海默病(AD)痴呆的诊断推荐指南近年来被修订,包括正电子发射断层扫描(PET,作为一种为神经退行性疾病诊断的活体成像技术诊断)。特别是PET,使用18Ffluorodeoxiglucouse([18F] FDG),能够在突触水平检测葡萄糖消耗非常早期的变化,能够支持早期和不同的AD诊断。在标准的临床试验中,[18F] FDG-PET图像的解释通常是通过定性评价的实现。目视检查,虽然只显示在人眼分辨率的信息,使在更高分辨率的信息被错过。此外,定性评估取决于临床医生的专业知识的程度,而防止精确和标准化的影像生物标志物的定义。自动化和计算机图像处理方法已经提出了支持脑PET研究的体内评价。特别是,客观的统计图像分析,能允许一个病人的图像与一群对照组的图像比较,已经给观察显著代谢变化带来了重要优势,包括更客观的可用性、跨中心的可靠指标和脑功能变化的检测能力的微妙,当病情发生在AD前驱。当前综述的目的是提供一个系统的概述,包括最近通过定量的方法对PET脑图像的统计分析在AD研究的前沿,对统计参数映射的特别关注。主要的成就,例如,将讨论在标准化的生物标志物的广告,以及灵敏度和特异性。
关键词: AD,老年痴呆,[18F]FDG
Current Alzheimer Research
Title:Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD
Volume: 13 Issue: 6
Author(s): Francesca Gallivanone, Pasquale Anthony Della Rosa, Isabella Castiglioni
Affiliation:
关键词: AD,老年痴呆,[18F]FDG
摘要: Recommended guidelines for the diagnosis of dementia due to Alzheimer’s Disease (AD) were revised in recent years, including Positron Emission Tomography (PET) as an in-vivo diagnostic imaging technique for the diagnosis of neurodegeneration. In particular PET, using 18Ffluorodeoxiglucouse ([18F]FDG), is able to detect very early changes of glucose consumption at the synaptic level, enabling to support both early and differential diagnosis of AD. In standard clinical practice, interpretation of [18F] FDG-PET images is usually achieved through qualitative assessment. Visual inspection although only reveals information visible at human eyes resolution, while information at a higher resolution is missed. Furthermore, qualitative assessment depends on the degree of expertise of the clinician, preventing from the definition of accurate and standardized imaging biomarkers. Automated and computerized image processing methods have been proposed to support the in-vivo assessment of brain PET studies. In particular, objective statistical image analyses, enabling the comparison of one patient’s images to a group of control images have been shown to carry important advantages for detecting significant metabolic changes, including the availability of more objective, cross-center reliable metrics and the detectability of brain subtle functional changes, as occurring in prodromal AD. The purpose of the current review is to provide a systematic overview encompassing the frontiers recently reached by quantitative approaches for the statistical analysis of PET brain images in the study of AD, with a particular focus on Statistical Parametric Mapping. Main achievements, e.g. in terms of standardized biomarkers of AD as well as of sensitivity and specificity, will be discussed.
Export Options
About this article
Cite this article as:
Francesca Gallivanone, Pasquale Anthony Della Rosa, Isabella Castiglioni , Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD, Current Alzheimer Research 2016; 13 (6) . https://dx.doi.org/10.2174/1567205013666151116142039
DOI https://dx.doi.org/10.2174/1567205013666151116142039 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
Current Cancer Drug Targets Gastrin-Releasing Peptide Receptor as a Molecular Target for Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Optimizing Modifiable and Lifestyle-related Factors in the Prevention of Dementia Disorders with Special Reference to Alzheimer, Parkinson and Autism Diseases
Current Nutrition & Food Science Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Green Tea Extract-Patents and Diversity of Uses
Recent Patents on Food, Nutrition & Agriculture Nanoparticulate Carrier Mediated Intranasal Delivery of Insulin for the Restoration of Memory Signaling in Alzheimer’s Disease
Current Nanoscience New Purine Nucleoside Analogs for Acute Lymphoblastic Leukemia
Clinical Cancer Drugs Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes
Current Gene Therapy Regulation and Function of DNA and Histone Methylations
Current Pharmaceutical Design The Targeted-liposome Delivery System of Antitumor Drugs
Current Drug Metabolism Alpha1-Antitrypsin Deficiency: Transition of Care for the Child With AAT Deficiency into Adulthood
Current Pediatric Reviews A Synopsis of Nano-Technological Approaches Toward Anti-Epilepsy Therapy: Present and Future Research Implications
Current Drug Metabolism Neuroprotective Role of Hypothermia in Hypoxic-ischemic Brain Injury: Combined Therapies using Estrogen
Current Neuropharmacology Neurocysticercosis: The Enigmatic Disease
Central Nervous System Agents in Medicinal Chemistry Prevalence of Cognitive Impairment and Dementia in Malays – Epidemiology of Dementia in Singapore Study
Current Alzheimer Research The Renin-Angiotensin System: Emerging Concepts
Current Hypertension Reviews The Radionuclide Molecular Imaging and Therapy of Neuroendocrine Tumors
Current Cancer Drug Targets STAT3 as a Therapeutic Target for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Acute and Long-Term Effects of Cannabis Use: A Review
Current Pharmaceutical Design Novel HSP90 Inhibitor NVP-AUY922 Enhances the Anti-tumor Effect of Temsirolimus Against Oral Squamous Cell Carcinoma
Current Cancer Drug Targets